NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · IEX Real-Time Price · USD
2.000
-0.020 (-0.99%)
At close: Jul 19, 2024, 12:00 AM
2.020
+0.020 (1.00%)
Pre-market: Jul 22, 2024, 9:13 AM EDT
NovaBay Pharmaceuticals Employees
As of December 31, 2023, NovaBay Pharmaceuticals had 26 total employees, including 24 full-time and 2 part-time employees. The number of employees decreased by 7 or -21.21% compared to the previous year.
Employees
26
Change (1Y)
-7
Growth (1Y)
-21.21%
Revenue / Employee
$547,423
Profits / Employee
-$713,538
Market Cap
2.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nuwellis | 59 |
cbdMD | 52 |
Windtree Therapeutics | 20 |
InMed Pharmaceuticals | 13 |
Phio Pharmaceuticals | 9 |
Tivic Health Systems | 9 |
Galmed Pharmaceuticals | 8 |
Quoin Pharmaceuticals | 4 |
NBY News
- 6 days ago - NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day - Business Wire
- 11 days ago - NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million - Business Wire
- 21 days ago - NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities - Business Wire
- 24 days ago - NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions - Business Wire
- 6 weeks ago - NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American - Business Wire
- 7 weeks ago - NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates - Business Wire
- 2 months ago - NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms - Business Wire
- 2 months ago - NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results - Business Wire